Natreon Healthy Skin Study - PrimaVie Supplement
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
This study will demonstrate the ability of the oral supplement, PrimaVie® to improve skin microperfusion, hydration, elasticity and barrier function. 45 females will be enrolled in 1 of 3 arms where they will receive either 125 mg PrimaVie, 250 mg PrimaVie or placebo (control) to take twice daily for 14 weeks.
Key facts
- Study ID
- NCT02762032
- Run by
- Ohio State University
- People needed
- 45
- Starts
- 2016-02-20
- Expected to finish
- 2019-12-20
- Last updated by the study team
- 2026-06-25
Who can join
Age: 30 and older, up to 65. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Subjects willing to discontinue any dietary or nutritional supplements, other than a general multivitamin, starting two weeks before onset of study and also during the study.
- Subjects must be willing to maintain their present diet with no major changes throughout the study.
- Subjects must be willing to take the dietary supplements as required by the study protocol twice daily.
- Female subjects must be between the ages of 30 to 65 years of age
- Subjects must provide written informed consent and are willing to comply with all study procedures.
You may not qualify if…
- Any dermatological disorder that may interfere with the accurate evaluation of the subject's skin.
- Subjects who are pregnant, breast feeding, or planning a pregnancy.
- Clinically significant unstable medical disorders.
- History of, diabetes, heart or kidney disease
- History of a psychological illness or condition that would interfere with their ability to understand and follow the requirements of the study.
- Any skin disease in the area of the upper inner arm where the biopsies will be obtained.
- Currently taking the following medications:
- Steroids
- Beta-blockers
- Immunosuppressant's
- Hydochlorothiazide,
- Statins
- Aspirin
- ACE Inhibitors
- Muscle relaxants
- Stimulants
- Prisoners
- Males
Where it is running
- OSU Hospital East — Columbus, Ohio, United States
- Davis Heart and Lung Research Institute — Columbus, Ohio, United States
- Martha Morehouse Medical Plaza 2050 Kenny Road — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.